AstraZeneca resolves Crestor patent spat with Generic Health
Intellectual Property March 1, 2018 7:23 pm By Christine Caulfield | Melbourne

Pharmaceutical companies AstraZeneca and Generic Health have laid down their swords in a long-running patent dispute over AstraZeneca’s cholesterol drug Crestor, two-and-a-half years after the […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.